Concert Pharmaceuticals (FRA:73C) Accumulated Depreciation : €0.00 Mil (As of Sep. 2022)

View and export this data going back to 2014. Start your Free Trial

What is Concert Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Concert Pharmaceuticals's annual accumulated depreciation increased from Dec. 2019 (€-2.63 Mil) to Dec. 2020 (€-3.29 Mil) and increased from Dec. 2020 (€-3.29 Mil) to Dec. 2021 (€-3.64 Mil).

Concert Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Concert Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concert Pharmaceuticals Accumulated Depreciation Chart

Concert Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Accumulated Depreciation

Get a 7-Day Free Trial

-6.23

-1.33

-2.63

-3.29

-3.64

Concert Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Accumulated Depreciation	Get a 7-Day Free Trial															-	-3.64	-	-	-

Concert Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Concert Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Concert Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Concert Pharmaceuticals (FRA:73C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concert Pharmaceuticals Inc (FRA:73C) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Hayden Avenue, Suite 3000N, Lexington, MA, USA, 02421

Website

https://www.concertpharma.com

Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company aims to discover and develop small-molecule drugs by incorporating new elements into known molecules or by leveraging the currently approved drugs to be used for new treatments. The pipeline consists of small molecules designed for oral administration to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, major depressive disorder, and Alzheimer's agitation.

Concert Pharmaceuticals (FRA:73C) Headlines

No Headlines